Letter to Editor
Is it Time to Consider Use of Levo-methadone (R-(-)-Methadone) to Replace Racemic Methadone?
Philip Lisberg and Feodor Scheinmann*
FSR Ltd., c/o Chittendens Accountants, 456 Chester Road, Manchester M16 9HD, UK
- *Corresponding Author:
- Feodor Scheinmann
Formerly Founding Director and CEO of Salford Ultrafine Chemicals and Research Ltd
Reader in Organic Chemistry at University of Salford
visiting Professor at Universities of Manchester
Liverpool and Zurich, UK
E-mail: [email protected]
Received Date: July 25, 2013; Accepted Date: August 14, 2013; Published Date: August 20, 2013
Citation: Lisberg P, Scheinmann F (2013) Is it Time to Consider Use of Levomethadone (R-(-)-Methadone) to Replace Racemic Methadone? J Develop Drugs 2:109. doi: 10.4172/2329-6631.1000109
Copyright: © 2013 Lisberg P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Racemic methadone, a mixture of its two enantiomeric optically active forms, R-(-)-Methadone and S-(+)-Methadone (also known as levo-methadone and dextro-methadone), was first synthesized in Germany before the outbreak of World War II.